155 related articles for article (PubMed ID: 17127787)
21. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.
Bacigalupo A; Giammarco S; Sica S
Int J Hematol; 2016 Aug; 104(2):168-74. PubMed ID: 27278666
[TBL] [Abstract][Full Text] [Related]
23. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
24. Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation.
Umeda K; Adachi S; Watanabe K; Kimura N; Lin Y; Nakahata T
Bone Marrow Transplant; 2002 Oct; 30(8):531-4. PubMed ID: 12379894
[TBL] [Abstract][Full Text] [Related]
25. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
[TBL] [Abstract][Full Text] [Related]
26. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
Trede NS; Warwick AB; Rosoff PM; Rohrer R; Bierer BE; Guinan E
Bone Marrow Transplant; 1997 Aug; 20(3):257-60. PubMed ID: 9257897
[TBL] [Abstract][Full Text] [Related]
28. Management of the refractory aplastic anemia patient: what are the options?
Marsh JC; Kulasekararaj AG
Blood; 2013 Nov; 122(22):3561-7. PubMed ID: 24052548
[TBL] [Abstract][Full Text] [Related]
29. Aplastic anaemia: management.
Killick SB; Marsh JC
Blood Rev; 2000 Sep; 14(3):157-71. PubMed ID: 10986151
[TBL] [Abstract][Full Text] [Related]
30. Calcineurin-inhibitor-induced pain syndrome after a second allogeneic bone marrow transplantation for a child with aplastic anemia.
Nishikawa T; Okamoto Y; Tanabe T; Shinkoda Y; Kodama Y; Tsuru Y; Kawano Y
Pediatr Transplant; 2009 Aug; 13(5):641-4. PubMed ID: 18785910
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic stem cell transplantation for acquired aplastic anemia.
Georges GE; Storb R
Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
[TBL] [Abstract][Full Text] [Related]
32. Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings.
Kobayashi R; Yabe H; Hara J; Morimoto A; Tsuchida M; Mugishima H; Ohara A; Tsukimoto I; Kato K; Kigasawa H; Tabuchi K; Nakahata T; Ohga S; Kojima S;
Br J Haematol; 2006 Dec; 135(5):693-6. PubMed ID: 17038001
[TBL] [Abstract][Full Text] [Related]
33. Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia.
Robak T; Kasznicki M; Strzelecka B; Bartkowiak J; Debiec-Rychter M
Leuk Lymphoma; 1999 Sep; 35(1-2):193-9. PubMed ID: 10512177
[TBL] [Abstract][Full Text] [Related]
34. [Acute monocytic leukemia following anti-lymphocyte immunoglobulin treatment in a patient with severe aplastic anemia].
Ohbayashi Y; Nagai M; Sasaki K; Murata M; Tasaka T; Kubota Y; Ikeda K; Takahara J; Irino S
Rinsho Ketsueki; 1993 May; 34(5):673-5. PubMed ID: 8315841
[TBL] [Abstract][Full Text] [Related]
35. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
[TBL] [Abstract][Full Text] [Related]
36. Aplastic anemia: pathogenesis and treatment.
Bacigalupo A
Hematology Am Soc Hematol Educ Program; 2007; ():23-8. PubMed ID: 18024605
[TBL] [Abstract][Full Text] [Related]
37. Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia.
Bader P; Klingebiel T; Klingel K; Föll J; Beck J; Handgretinger R; Ehninger G; Deeg HJ; Niethammer D
Bone Marrow Transplant; 1995 Sep; 16(3):479-81. PubMed ID: 8535324
[TBL] [Abstract][Full Text] [Related]
38. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
[TBL] [Abstract][Full Text] [Related]
39. The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea.
Kim I; Yoon SS; Park S; Kim BK; Kim NK
J Korean Med Sci; 2003 Jun; 18(3):365-71. PubMed ID: 12808323
[TBL] [Abstract][Full Text] [Related]
40. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
